PHOENIX, AZ / ACCESSWIRE / July 22, 2019 / The Stock Day Podcast welcomed CanaQuest Medical Corp (OTC PINK: CANQF) (“the Company”), a company engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. President and Co-Founder, Paul Ramsay, joined Stock Day host Everett Jolly.
Jolly began the interview by asking Ramsay to provide some background information about the Company and their projects. Ramsay explained that the Company is focused on the development of proprietary research and products using cannabis and algae oils. “We’ve had really great results and it has put us in a position to bring out our first CBD and THC based product,” stated Ramsay.
“We’re focused on treating anxiety, depression, addiction, schizophrenia, and post-traumatic stress disorder,” Ramsay shared. He also explained that the Company’s products will also be effective in treating pain management, which makes them a suitable alternative to opioids.
Jolly then asked about the Company’s competitive edge given the growing cannabis industry. Ramsay shared that the Company will only release products that are backed by scientific research and proven results.
Jolly followed by asking about the Company’s plan for raising funds. Ramsay explained that the Company’s business plan is always evolving, and they are currently looking to raise $3 million, which will allow them to begin generating revenue.
Ramsay also shared that the Company has a strong focus on the nutraceutical space and expects to bring these types of products to market within a few months.
To close the interview, Ramsay shared that the Company is continuing to build their brand and is proud to be on the verge of releasing products that are backed by thorough scientific research. He also explained that he expects the Company to grow quickly, making it a great investment for interested shareholders. “We’re ready to start making money,” closed Ramsay.
To hear Paul Ramsay’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7320939-canaquest-medical-corp-joins-the-stock-day-podcast-corporation-to-discuss-their-rapid-growth-plan
About CanaQuest Medical Corp
CanaQuest Medical Corp is engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. The Company has engaged two Canadian universities to provide research into the use of botanical extracts and cannabis formulations, which the company plans to use to develop products that combine the significant health benefits of Omega 3s, derived from algae oil, other botanical extracts and extracts from cannabis oil. Our research is focused on the use of cannabis in the context of cancer and the use of cannabis derivatives for the development of our novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder “PTSD”. CanaQuest is also in the process of obtaining a purchase/sale, import/export license for cannabis and cannabis products (non-possession) as permitted under the Health Canada Cannabis Act.
For more information, visit our website at https://www.canaquest.com
This news release contains “forward-looking statements” as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Paul Ramsay, Co-Founder & President, CanaQuest Medical Corp
About The “Stock Day” Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
Stock Day Media
SOURCE: Stock Day Media
View source version on accesswire.com: